- Home
- MRNA vs FTAI Comparison
MRNA vs FTAI Comparison
Compare MRNA & FTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- FTAI
- Stock Information
- Founded
- MRNA 2010
- FTAI 2011
- Country
- MRNA United States
- FTAI United States
- Employees
- MRNA N/A
- FTAI N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- FTAI Misc Corporate Leasing Services
- Sector
- MRNA Health Care
- FTAI Industrials
- Exchange
- MRNA Nasdaq
- FTAI Nasdaq
- Market Cap
- MRNA 13.4B
- FTAI 11.4B
- IPO Year
- MRNA 2018
- FTAI 2015
- Fundamental
- Price
- MRNA $34.15
- FTAI $117.18
- Analyst Decision
- MRNA Hold
- FTAI Strong Buy
- Analyst Count
- MRNA 20
- FTAI 12
- Target Price
- MRNA $46.76
- FTAI $171.83
- AVG Volume (30 Days)
- MRNA 9.4M
- FTAI 2.2M
- Earning Date
- MRNA 08-01-2025
- FTAI 07-29-2025
- Dividend Yield
- MRNA N/A
- FTAI 1.02%
- EPS Growth
- MRNA N/A
- FTAI N/A
- EPS
- MRNA N/A
- FTAI 0.25
- Revenue
- MRNA $3,177,000,000.00
- FTAI $1,910,287,000.00
- Revenue This Year
- MRNA N/A
- FTAI $36.95
- Revenue Next Year
- MRNA $9.70
- FTAI $20.71
- P/E Ratio
- MRNA N/A
- FTAI $452.16
- Revenue Growth
- MRNA N/A
- FTAI 58.55
- 52 Week Low
- MRNA $23.15
- FTAI $75.06
- 52 Week High
- MRNA $125.68
- FTAI $181.64
- Technical
- Relative Strength Index (RSI)
- MRNA 64.57
- FTAI 52.86
- Support Level
- MRNA $30.88
- FTAI $109.90
- Resistance Level
- MRNA $35.59
- FTAI $115.15
- Average True Range (ATR)
- MRNA 1.48
- FTAI 4.19
- MACD
- MRNA 0.11
- FTAI 0.16
- Stochastic Oscillator
- MRNA 74.05
- FTAI 79.04
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About FTAI FTAI Aviation Ltd.
FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.